A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
NCT ID: NCT06806592
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
400 participants
INTERVENTIONAL
2025-09-13
2027-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants are put into 2 groups randomly, which means by chance. One group takes nerandomilast tablets and the other group takes placebo tablets. Placebo tablets look like nerandomilast tablets but do not contain any medicine. Participants take a tablet 2 times a day for at least 26 weeks and up to 1 year. Participants continue immunosuppressant treatment for their underlying rheumatic disease.
Participants are in the study for about 7.5 to 13 months depending on when they join the study. During this time, they visit the study site about 9 to 10 times. At study visits, participants have lung function tests. At select visits, chest imaging is performed. Participants fill in questionnaires about their symptoms and quality of life. The results between the 2 groups are compared to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nerandomilast
Participants with SARD-ILDs will receive nerandomilast.
Nerandomilast
Nerandomilast
Placebo
Participants with SARD-ILDs will receive placebo.
Placebo matching nerandomilast
Placebo matching nerandomilast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nerandomilast
Nerandomilast
Placebo matching nerandomilast
Placebo matching nerandomilast
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis by a rheumatologist with at least 1 of the following SARDs: Rheumatoid arthritis (RA), systemic sclerosis (SSc) (participants must be anticentromere auto-antibody negative), idiopathic inflammatory myopathy (IIM), Sjögren's disease, or Mixed connective tissue disease (MCTD)
* Presence of fibrotic interstitial lung disease (ILD) on high-resolution computed tomography (HRCT), defined as presence of reticular abnormality with traction bronchiectasis with or without honeycombing (HC), with disease extent \>10% on HRCT performed within 12 months of Visit 1 or, if historical scan is not available, on baseline HRCT taken prior to Visit 2, as confirmed by central review
* No lung function improvement and no clinically significant ILD improvement as a treatment response to immunosuppressant (IS) therapy according to both criteria:
* No improvement in absolute forced vital capacity (FVC) % predicted \>5% within the 15 months prior to Visit 1, as measured by 2 spirometry assessments that must be ≥3 months apart. (Note: Visit 1 spirometry may be used to fulfill the inclusion criterion if there is only 1 spirometry reading in the 15 months prior to Visit 1)
* No clinically significant improvement in ILD based on clinician's judgement (including symptoms, imaging/HRCT, or other assessments as considered relevant and documented by the Investigator)
* FVC ≥45% of predicted normal at Visit 1
* Diffusing capacity of the lungs for carbon monoxide (DLCO) ≥25% of predicted normal corrected for haemoglobin (Hb) within 3 months prior to or at Visit 1
* Participants must be on stable treatment with any IS agent for ≥6 months (or ≥3 months for participants with IIM-ILD) with the following specifications:
* If using prednisone, participants must be on stable dose for ≥4 weeks prior to Visit 2
* If using rituximab, participants must have completed their first cycle \>6 months prior to Visit 2
* If using nintedanib, participants must be on a stable dose for ≥12 weeks prior to Visit 2
* In the opinion of the Investigator, no change in background standard of care (SoC) treatment with immunosuppressant (IS), immunomodulator (IM), or nintedanib is planned
Exclusion Criteria
* Prebronchodilator forced expiratory volume in 1 second (FEV1)/ forced vital capacity (FVC) \<0.7 at Visit 1
* Acute ILD exacerbation within 3 months prior to Visit 1 and/or during the screening period, based on Investigator judgement
* Active vasculitis, unstable or uncontrolled within 8 weeks prior to Visit 1 or during the screening period
* Any suicidal behaviour in the past 2 years
* Any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (C-SSRS) in the past 3 months or at Visit 1, and/or at Visit 2
* Use of any of the following medications: cyclophosphamide within 6 months of Visit 1, pirfenidone within 8 weeks of Visit 1
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Mayo Clinic-Arizona
Scottsdale, Arizona, United States
University of California Los Angeles
Los Angeles, California, United States
Paradigm Clinical Research - San Diego
San Diego, California, United States
National Jewish Health
Denver, Colorado, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Meris Clinical Research-Brandon-69466
Brandon, Florida, United States
Miami VA Healthcare System
Miami, Florida, United States
Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead
Atlanta, Georgia, United States
Augusta University
Augusta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Northshore University Health System
Evanston, Illinois, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
LSU Health Sciences Center
New Orleans, Louisiana, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Northwell Health
Great Neck, New York, United States
NYU Langone Health
New York, New York, United States
Columbia University Medical Center-New York Presbyterian Hospital
New York, New York, United States
Onsite Clinical Solutions
Salisbury, North Carolina, United States
Southeastern Research Center-Winston Salem-69289
Winston-Salem, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Temple Lung Center
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
University of Utah Health Sciences Center
Salt Lake City, Utah, United States
Rheumatology and Pulmonary Clinic
Beckley, West Virginia, United States
University of Wisconsin
Madison, Wisconsin, United States
Royal Prince Alfred Hospital
Camperdown, Sydney, New South Wales, Australia
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, Australia
The Prince Charles Hospital
Chermside, Queensland, Australia
Austin Hospital
Heidelberg, Victoria, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Krems University Hospital
Krems, , Austria
AKH - Medical University of Vienna
Vienna, , Austria
Klinikum Wels - Grieskirchen GmbH
Wels, , Austria
Beijing Chao-Yang Hospital
Beijing, , China
China-Japan Friendship Hospital
Beijing, , China
Peking Union Medical College Hospital
Beijing, , China
West China Hospital of Sichuan University
Chengdu, , China
People's Hospital of Sichuan Province
Chengdu, , China
Guangdong Provincial People's Hospital
Guangzhou, , China
The First Affiliated Hospital, Zhejiang University
Hangzhou, , China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, , China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, , China
University Hospital_Macau University of Science and Technology
Macau, , China
The First Affiliated Hospital of Nanchang University
Nanchang, , China
Huashan Hospital, Fudan University
Shanghai, , China
Tianjin Medical University General Hospital
Tianjin, , China
Wuhan Union Hospital
Wuhan, , China
Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T
Wuhan, , China
First Affiliated Hospital of Xiamen University
Xiamen, , China
Zhuzhou Central Hospital
Zhuzhou, , China
HOP d'Angers
Angers, , France
HOP Pellegrin
Bordeaux, , France
HOP Claude Huriez
Lille, , France
Hôpital Cochin
Paris, , France
HOP Bichat
Paris, , France
HOP Sud
Rennes, , France
HOP Civil
Strasbourg, , France
HOP Rangueil
Toulouse, , France
Charite Universitätsmedizin Berlin KöR
Berlin, , Germany
Immanuel-Krankenhaus GmbH
Berlin, , Germany
Universitätsklinikum Bonn AöR
Bonn, , Germany
Städtisches Klinikum Braunschweig gGmbH
Braunschweig, , Germany
Gesundheit Nord gGmbH | Klinikverbund Bremen
Bremen, , Germany
Krankenhaus Porz am Rhein gGmbH
Cologne, , Germany
Universitätsklinikum Düsseldorf
Düsseldorf, , Germany
Universitätsklinikum Erlangen
Erlangen, , Germany
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH
Essen, , Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, , Germany
Helios Fachklinik Vogelsang-Gommern GmbH
Gommern, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
Herne, , Germany
medius Kliniken gGmbH
Kirchheim unter Teck, , Germany
Klinikum Konstanz
Konstanz, , Germany
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Lübeck, , Germany
Johannes Wesling Klinikum Minden
Minden, , Germany
Klinikum der Universität München AÖR
München, , Germany
Krankenhaus Barmherzige Brüder Regensburg
Regensburg, , Germany
ASST degli Spedali Civili di Brescia
Brescia, , Italy
A. O. Universitaria Careggi
Frienze, , Italy
Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico
Milan, , Italy
Ospedale San Raffaele S.r.l.
Milan, , Italy
Azienda Ospedaliera Policlinico di Modena
Modena, , Italy
Università degli Studi Padova
Padua, , Italy
Fondazione IRCCS Policlinico S. Matteo
Pavia, , Italy
AOU Policlinico Umberto I
Roma, , Italy
Fujita Health University Hospital
Aichi, Toyoake, , Japan
Hospital of the University of Occupational and Environmental Health
Fukuoka, Kitakyushu, , Japan
Hiroshima University Hospital
Hiroshima, Hiroshima, , Japan
Sapporo Medical University Hospital
Hokkaido, Sapporo, , Japan
Hokkaido University Hospital
Hokkaido, Sapporo, , Japan
Kagawa University Hospital
Kagawa, Kita-gun, , Japan
St. Marianna University Hospital
Kanagawa, Kawasaki, , Japan
Kitasato University Hospital
Kanagawa, Sagamihara, , Japan
Kyoto University Hospital
Kyoto, Kyoto, , Japan
Nagasaki University Hospital
Nagasaki, Nagasaki, , Japan
Osaka Medical and Pharmaceutical University Hospital
Osaka, Takatsuki, , Japan
Saitama Medical University Hospital
Saitama, Iruma-gun, , Japan
Juntendo University Hospital
Tokyo, Bunkyo-Ku, , Japan
Nippon Medical School Hospital
Tokyo, Bunkyo-ku, , Japan
Keio University Hospital
Tokyo, Shinjuku-ku, , Japan
Investigacion y Biomedicina de Chihuahua S.C.
Chihuahua City, , Mexico
Centro Integral en Reumatologia, SA. de CV.
Guadalajara, , Mexico
Soltmed Smo
Mexico City, , Mexico
CITER Centro de Investigación y Tratamiento de las Enfermedades Reumaticas SA de CV
Mexico City, , Mexico
Inst Nac de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, , Mexico
Medical Care & Research SA de CV
Mérida, , Mexico
Hospital Universitario Dr Jose Eleuterio Gonzalez
Monterrey, , Mexico
Zuyderland Medisch Centrum
Heerlen, , Netherlands
St. Antonius ziekenhuis, locatie Nieuwegein
Nieuwegein, , Netherlands
Erasmus Medisch Centrum-ROTTERDAM-50697
Rotterdam, , Netherlands
Akershus Universitetssykehus HF
Nordbyhagen, , Norway
Sykehuset Telemark HF, Avd. Skien
Skien, , Norway
GCM Medical Group, PSC
San Juan, , Puerto Rico
Seoul National University Bundang Hospital
Seongnam, , South Korea
Kyung Hee University Hospital
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Soonchunhyang University Hospital Seoul
Seoul, , South Korea
Hospital Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Universitari Vall D Hebron
Barcelona, , Spain
Hospital de Basurto
Bilbao, , Spain
Hospital Universitario Reina Sofía
Córdoba, , Spain
Hospital Juan Ramón Jimenez
Huelva, , Spain
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, , Spain
Hospital Universitario Ramon Y Cajal
Madrid, , Spain
Fundación Jiménez Díaz
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Clínico de Santiago
Santiago de Compostela, , Spain
Hospital Universitario Virgen De La Macarena
Seville, , Spain
Hospital Virgen del Rocío
Seville, , Spain
Hospital Dr. Peset
Valencia, , Spain
Complejo Hospitalario Universitario de Vigo
Vigo, , Spain
Cantonal Hospital of Aarau
Aarau, , Switzerland
Universitätsspital Basel
Basel, , Switzerland
Hopitaux Universitaires de Geneve (HUG)
Geneva, , Switzerland
Neuchatel Hospital Network
Neuchâtel, , Switzerland
Kantonsspital St.Gallen
Sankt Gallen, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Antrim Area Hospital
Antrim, , United Kingdom
Royal United Hospital, Bath
Bath, , United Kingdom
Heartlands Hospital
Birmingham, , United Kingdom
Chapel Allerton Hospital
Leeds, , United Kingdom
St George's Hospital-London-26733
London, , United Kingdom
University College Hospital
London, , United Kingdom
Altnagelvin Area Hospital
Londonderry, , United Kingdom
Luton & Dunstable University Hospital
Luton, , United Kingdom
NIHR Lancashire Clinical Research Facility
Preston, , United Kingdom
Northern General Hospital
Sheffield, , United Kingdom
Royal Cornwall Hospital
Truro, , United Kingdom
Southend University Hospital
Westcliffe-on-Sea, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Boehringer Ingelheim
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-512849-17-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
U1111-1305-5857
Identifier Type: REGISTRY
Identifier Source: secondary_id
1305-0046
Identifier Type: -
Identifier Source: org_study_id